Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies - PubMed

Affiliations

• PMID: 11551942
• DOI: 10.1074/jbc.M106582200

Free article

Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies

N Zhou et al. J Biol Chem. 2001.

Free article

Abstract

The human CXC chemokine receptor 4 (CXCR4) is a receptor for the chemokine stromal cell-derived factor (SDF-1alpha) and a co-receptor for the entry of specific strains of human immunodeficiency virus type I (HIV-1). CXCR4 is also recognized by an antagonistic chemokine, the viral macrophage inflammatory protein II (vMIP-II) encoded by human herpesvirus type VIII. SDF-1alpha or vMIP-II binding to CXCR4 can inhibit HIV-1 entry via this co-receptor. An approach combining protein structural modeling and site-directed mutagenesis was used to probe the structure-function relationship of CXCR4, and interactions with its ligands SDF-1alpha and vMIP-II and HIV-1 envelope protein gp120. Hypothetical three-dimensional structures were proposed by molecular modeling studies of the CXCR4.SDF-1alpha complex, which rationalize extensive biological information on the role of CXCR4 in its interactions with HIV-1 envelope protein gp120. With site-directed mutagenesis, we have identified that the amino acid residues Asp (D20A) and Tyr (Y21A) in the N-terminal domain and the residue Glu (E268A) in extracellular loop 3 (ECL3) are involved in ligand binding, whereas the mutation Y190A in extracellular loop 2 (ECL2) impairs the signaling mediated by SDF-1alpha. As an HIV-1 co-receptor, we found that the N-terminal domain, ECL2, and ECL3 of CXCR4 are involved in HIV-1 entry. These structural and mutational studies provide valuable information regarding the structural basis for CXCR4 activity in chemokine binding and HIV-1 viral entry, and could guide the design of novel targeted inhibitors.

Similar articles

• Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.

  Brelot A, Heveker N, Montes M, Alizon M. Brelot A, et al. J Biol Chem. 2000 Aug 4;275(31):23736-44. doi: 10.1074/jbc.M000776200. J Biol Chem. 2000. PMID: 10825158

• Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.

  Choi WT, Tian S, Dong CZ, Kumar S, Liu D, Madani N, An J, Sodroski JG, Huang Z. Choi WT, et al. J Virol. 2005 Dec;79(24):15398-404. doi: 10.1128/JVI.79.24.15398-15404.2005. J Virol. 2005. PMID: 16306611 Free PMC article.

• Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.

  Tian S, Choi WT, Liu D, Pesavento J, Wang Y, An J, Sodroski JG, Huang Z. Tian S, et al. J Virol. 2005 Oct;79(20):12667-73. doi: 10.1128/JVI.79.20.12667-12673.2005. J Virol. 2005. PMID: 16188969 Free PMC article.

• Structural studies of chemokines that inhibit HIV-1 entry.

  Fernandez EJ, Lolis E. Fernandez EJ, et al. Antivir Chem Chemother. 2001;12 Suppl 1:43-9. Antivir Chem Chemother. 2001. PMID: 11594687 Review.

• Modulators of CXCR4 and CXCR7/ACKR3 Function.

  Adlere I, Caspar B, Arimont M, Dekkers S, Visser K, Stuijt J, de Graaf C, Stocks M, Kellam B, Briddon S, Wijtmans M, de Esch I, Hill S, Leurs R. Adlere I, et al. Mol Pharmacol. 2019 Dec;96(6):737-752. doi: 10.1124/mol.119.117663. Epub 2019 Sep 23. Mol Pharmacol. 2019. PMID: 31548340 Review.

Cited by

• Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes.

  Sand LG, Szuhai K, Hogendoorn PC. Sand LG, et al. Int J Mol Sci. 2015 Jul 16;16(7):16176-215. doi: 10.3390/ijms160716176. Int J Mol Sci. 2015. PMID: 26193259 Free PMC article. Review.

• Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.

  Tamamis P, Floudas CA. Tamamis P, et al. J Chem Inf Model. 2014 Apr 28;54(4):1174-88. doi: 10.1021/ci500069y. Epub 2014 Apr 8. J Chem Inf Model. 2014. PMID: 24660779 Free PMC article.

• Functional mimetic of the G-protein coupled receptor CXCR4 on a soluble antibody scaffold.

  Koksal AC, Pennini ME, Marelli M, Xiao X, Dall'Acqua WF. Koksal AC, et al. MAbs. 2019 May/Jun;11(4):725-734. doi: 10.1080/19420862.2019.1596703. Epub 2019 Apr 16. MAbs. 2019. PMID: 30900513 Free PMC article.

• Sequential tyrosine sulfation of CXCR4 by tyrosylprotein sulfotransferases.

  Seibert C, Veldkamp CT, Peterson FC, Chait BT, Volkman BF, Sakmar TP. Seibert C, et al. Biochemistry. 2008 Oct 28;47(43):11251-62. doi: 10.1021/bi800965m. Epub 2008 Oct 4. Biochemistry. 2008. PMID: 18834145 Free PMC article.

• Bioinformatic analysis of HIV-1 entry and pathogenesis.

  Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B. Aiamkitsumrit B, et al. Curr HIV Res. 2014;12(2):132-61. doi: 10.2174/1570162x12666140526121746. Curr HIV Res. 2014. PMID: 24862329 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program